Circulating Biomarkers Determining Inflammation in Atherosclerosis Progression

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|22|22|2619-2635

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.22, Iss.22, 2015-08, pp. : 2619-2635

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Infection-Associated Biomarkers of Inflammation in Atherosclerosis

By  

Current Pharmaceutical Design, Vol. 21, Iss. 13, 2015-04 ,pp. : 1776-1782

Bentham Science Publishers

Access to resources Recommend Favorite

Circulating Advanced Oxidation Protein Products as Oxidative Stress Biomarkers and Progression Mediators in Pathological Conditions Related to Inflammation and Immune Dysregulation

By  

Current Medicinal Chemistry, Vol. 23, Iss. 34, 2016-10 ,pp. : 3862-3882

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNAs Determining Inflammation as Novel Biomarkers and Potential Therapeutic Targets

By  

Current Medicinal Chemistry, Vol. 22, Iss. 22, 2015-08 ,pp. : 2666-2679

Bentham Science Publishers

Access to resources Recommend Favorite

Gliclazide, Inflammation and Atherosclerosis

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 7, Iss. 3, 2008-09 ,pp. : 224-230

Bentham Science Publishers

Access to resources Recommend Favorite

HDL and Inflammation in Atherosclerosis

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 1, 2004-03 ,pp. : 51-57

Bentham Science Publishers

Access to resources Recommend Favorite